H. Morr

发表

Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years

Florian Kronenberg, Thomas Illig, Heike Bickeböller, 2008, BMC Cancer.

Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer

N. Bitterlich, E. Eigenbrodt, N. Bitterlich, 2002, International Journal of Clinical Oncology.

Guidelines of the German Respiratory Society for Diagnosis and Treatment of Adults Suffering from Acute or Chronic Cough

H. Sitter, L. Klimek, A. Gillissen, 2010, Pneumologie.

Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study.

E. Eigenbrodt, H. Morr, J. Schneider, 2003, Cancer letters.

Tumor cells in intraoperative pleural lavage. An indicator for the poor prognosis of bronchogenic carcinoma

H. Morr, K. Berghäuser, J. Buhr, 1990, Cancer.

[COPD and psychopathology: a review].

A. Gillissen, G. Schultze-Werninghaus, H. Worth, 2005, Pneumologie.

[Recommendations on the diagnosis of bronchial carcinoma. German Pneumology Society].

U. Gatzemeier, D. Ukena, H. Morr, 2000, Pneumologie.

Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study

W. Seeger, A. Günther, F. Grimminger, 2007, European Respiratory Journal.

Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease.

W. Seeger, A. Günther, Andreas Günther, 2002, American journal of physiology. Lung cellular and molecular physiology.

COPD und Begleiterkrankungen Ergebnisse des Expertentreffens Luftschlösser 2008 Tremsbüttel, 28.–29. November 2008 Sponsor: Boehringer Ingelheim Pharma GmbH&Co KG

H. Magnussen, A. Gillissen, H. Teschler, 2009 .

Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.

W. Seeger, A. Günther, Andreas Günther, 1999, The European respiratory journal.

Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.

W. Seeger, F. Grimminger, C. Siebert, 1996, The European respiratory journal.

Enhanced Tissue Factor Pathway Activity and Fibrin Turnover in the Alveolar Compartment of Patients with Interstitial Lung Disease

C. Ruppert, W. Seeger, A. Günther, 2000, Thrombosis and Haemostasis.

Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.

W. Seeger, A. Günther, F. Grimminger, 1996, American journal of respiratory and critical care medicine.

Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene

J. Chang-Claude, H. Dienemann, H. Wichmann, 2008, BMC Cancer.

Leitlinien zur Langzeit-Sauerstofftherapie

H. Sitter, H. Magnussen, H. Worth, 2008, Pneumologie.

[Three cases of a fulminant course of idiopathic pulmonary fibrosis (Hamman-Rich syndrome)].

W. Seeger, N. Suttorp, H. Morr, 1993, Pneumologie.

Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.

E. Eigenbrodt, H. Morr, J. Schneider, 2000, Cancer detection and prevention.

Influence of Inhalation Anaesthetics on Bronchomotor Tone — Animal Experiments on Vago‐Vagal Reflex Bronchoconstriction

H. Morr, U. Morr-Strathmann, 1979 .

Effect of disodium cromoglycate (Intal®) on antigen-induced histamine release from passively sensitized human lung in vitro

H. Morr, H. Morr, 1978, Lung.

[Clinical experiences with the Gianturco-Z stent in endotracheal and -bronchial stenoses].

W. Jaschke, K. Rauber, H. Morr, 1992, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients

N. Bitterlich, E. Eigenbrodt, N. Bitterlich, 2003, Clinical and Experimental Medicine.

Comparison of Pancreatic Function and Life Quality After Whipple and Duodenum-Preserving Resection

H. Morr, J. Menzel, I. Baća, 1993 .

Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer.

E. Eigenbrodt, H. Morr, J. Schneider, 2000, Anticancer research.

[Six-minute walk test in chronic lung and heart disease - technical aspects, interpretation, limitations].

H. Morr, P. Hien, 2002, Pneumologie.

[Assessment and outcome parameters in COPD].

H. Magnussen, T. Welte, A. Gillissen, 2009, Pneumologie.

[Gastrointestinal hemorrhage as a complication in chronic peritoneal dialysis].

H. Morr, H. Siemensen, F. Maetzel, 1972, Die Medizinische Welt.

Exocrine and Endocrine Pancreatic Secretion Following Pancreatic Resection

H. Morr, J. Menzel, I. Baća, 1993 .

Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.

Joachim Schneider, H. Morr, J. Schneider, 2003, Anticancer research.

Immunological Release of Histamine from Human Lung

H. Morr, 1979 .

Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases.

W. Seeger, F. Grimminger, U. Maus, 1999, Clinical and experimental immunology.

[Guidelines to long-term oxygen therapy].

H. Worth, H. Morr, G. Goeckenjan, 2001, Pneumologie.

Beurteilungs- und Prognosekriterien bei COPD1

H. Magnussen, H. Teschler, G. Schultze-Werninghaus, 2009, Pneumologie.

COPD und Infektion

T. Welte, H. Watz, H. Worth, 2010, Pneumologie.

Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von erwachsenen Patienten mit akutem und chronischem Husten

H. Worth, K. Fuchs, T. Voshaar, 2010, Pneumologie.

Leitlinien zur Langzeit-Sauerstofftherapie

H. Worth, H. Magnussen, H. Morr, 2001 .

[Precipitin tests in allergic lung disease (author's transl)].

P. von Wichert, H. Morr, E. Hain, 1974, Pneumonologie. Pneumonology.